BioPharma Resources

Drug Trial Radar · NCT07752407

A Study to Evaluate the Efficacy and Safety of Vonoprazan 10 mg Compared to Placebo for Relief of Episodic Heartburn in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease Through 24 Weeks

A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Vonoprazan 10 mg Compared to Placebo for Relief of Episodic Heartburn in Subjects With Symptomatic Non-Erosive Gastroesophageal Reflux Disease Through 24 Weeks

Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 500 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

500

Planned (sponsor's estimate)

Start

Sep 25, 2026

Primary completion

Oct 20, 2027

Study completion Jan 19, 2028

Sponsor

Lead sponsor
Phathom Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
Aug 7, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main objective is to assess the efficacy of vonoprazan (10 mg as needed) compared to placebo (as needed) in relief of episodic heartburn at 2 hours that is sustained for 24 hours over 12 weeks of treatment in participants with non-erosive gastroesophageal reflux disease (GERD).

Conditions

  • Symptomatic Non-erosive Gastroesophageal Reflux Disease

Interventions

  • VonoprazanDrug

    Oral tablet.

  • PlaceboDrug

    Oral tablet.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Treated Heartburn Episodes Achieving Complete Relief at 2 Hours and Sustained Relief for 24 Hours up to Week 12Time frame: Up to Week 12

Locations

26 sites in 1 country. Site status is shown where the registry gives one.

  • Elite Clinical Studies, LLC

    Phoenix, Arizona · Recruiting

  • Gastro SBClinical Research

    Chula Vista, California · Recruiting

  • GW Research, Inc.

    Chula Vista, California · Recruiting

  • Torrance Clinical Research Institute, Inc.

    Lomita, California · Recruiting

  • Paragon Rx Clinical, Inc.

    Santa Ana, California · Recruiting

  • Peak Gastroenterology Associates

    Colorado Springs, Colorado · Recruiting

  • Guardian Angel Research Center, INC

    Tampa, Florida · Recruiting

  • International Center for Research

    Tampa, Florida · Recruiting

  • Atlanta Center for Clinical Research

    Roswell, Georgia · Recruiting

  • Treasure Valley Medical Research

    Boise, Idaho · Recruiting

  • Grand Teton Research Group

    Idaho Falls, Idaho · Recruiting

  • Alpine Healthcare Family Practice

    Las Vegas, Nevada · Recruiting

  • Digestive Disease Specialists

    Las Vegas, Nevada · Recruiting

  • Advanced Research Institute

    Reno, Nevada · Recruiting

  • Drug Trials America

    Hartsdale, New York · Recruiting

  • Peters Medical Research, LLC

    High Point, North Carolina · Recruiting

  • Great Lakes Gastroenterology Research LLC

    Mentor, Ohio · Recruiting

  • Quality Medical Research

    Nashville, Tennessee · Recruiting

  • Texas Digestive Specialists

    Harlingen, Texas · Recruiting

  • Victorium Clinical Research LTD CO

    Houston, Texas · Recruiting

  • Biopharma Informatic, LLC

    Houston, Texas · Recruiting

  • Biopharm Informatic, LLC

    McAllen, Texas · Recruiting

  • Quality Research Inc.

    San Antonio, Texas · Recruiting

  • Gastroenterology Research of San Antonio

    San Antonio, Texas · Recruiting

  • Advanced Research Institute

    Ogden, Utah · Recruiting

  • Advanced Clinical Research

    Sandy City, Utah · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.